arbtrage.com checking… Sign in

Liminatus Pharma, Inc.

LIMN
$0.14
▼ -6.0% Today
as of Jun 7, 07:20 ET
Last 30 days -30.39% Apr 28 → Jun 05
$0.13 $0.16 $0.19 $0.22 $0.25 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$0.15
High
$0.15
Low
$0.14
Volume
$3M
Avg Vol
$5M
Mkt Cap
$8M
P/E (TTM)
Beta
52w High
$33.66
52w Low
$0.13
Div Yield
Shares Out
$45M

Overview

52-week range
$0.13
$34
0% of range
Avg surprise (last 0)
Avg reaction (last 1)
-2.2%
0% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.47$-1.86$-1.25$-0.63$-0.02 Actual $-2.47Actual $-0.05Actual $-0.03Actual $-0.02Actual $-0.07Actual $-0.03 MarJunSepMarJunSepMar/2026
Revenue vs Net Income Revenue Net income
$-2M$-1M$-852,200$-366,624$118,951 Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 15, 2026Mar/2026 $-0.03 -2.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.07 financials
Mon Jun 30, 2025Jun 2025 financials
Mon Mar 31, 2025Mar 2025 $-0.02 financials
Mon Sep 30, 2024Sep 2024 $-0.03 financials
Sun Jun 30, 2024Jun 2024 $-0.05 financials
Sun Mar 31, 2024Mar 2024 $-2.47 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-1M$-701,170$-1M$-264,220$-543,147$-909,218
Net income$-1M$-2M$113,287$-327,526$-601,372$-961,207
EPS (diluted)$-0.03$-0.07$-0.02$-0.03$-0.05

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$2M$337,655$724,502$1M$56,319
Inventory
Total current assets$3M$500,574$1M$2M$5M
Total assets$3M$512,795$1M$2M$5M
Long-term debt
Total liabilities$3M$10M$3M$11M$1,060$25M
Total equity$-132,596$-10M$-2M$-9M$-20M$-19M$-19M$-19M

Implied volatility — last 90 days

No IV snapshots yet for LIMN.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.